I posed the other day that Neuren was not "Hot", hence the relatively depressed SP.
After reading the quarterly, I wonder whether the fact that Neuren cannot progress 2591 for any indications that Acadia pursues with Daybue is causing people to question the value. It seems very open ended and could mean that Acadia could commence a P1 trial for Daybue in any indication just to snooker Neuren.
Could be completely wrong but I wonder whether that plays a part.
Ann: Q2 2023 quarterly activity and cash flow report, page-7
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.65 |
Change
0.790(3.98%) |
Mkt cap ! $2.583B | |||
| Open | High | Low | Value | Volume |
| $20.00 | $20.66 | $19.94 | $3.648M | 179.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 476 | $20.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.67 | 1005 | 5 |
View Market Depth
| Last trade - 13.03pm 12/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |